GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Shiller PE Ratio

CSPC Pharmaceutical Group (HKSE:01093) Shiller PE Ratio : 11.41 (As of May. 15, 2024)


View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group Shiller PE Ratio?

As of today (2024-05-15), CSPC Pharmaceutical Group's current share price is HK$6.73. CSPC Pharmaceutical Group's E10 for the quarter that ended in Dec. 2023 was HK$0.59. CSPC Pharmaceutical Group's Shiller PE Ratio for today is 11.41.

The historical rank and industry rank for CSPC Pharmaceutical Group's Shiller PE Ratio or its related term are showing as below:

HKSE:01093' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.78   Med: 10.48   Max: 12.15
Current: 11.43

During the past years, CSPC Pharmaceutical Group's highest Shiller PE Ratio was 12.15. The lowest was 9.78. And the median was 10.48.

HKSE:01093's Shiller PE Ratio is ranked better than
83.83% of 532 companies
in the Drug Manufacturers industry
Industry Median: 25.285 vs HKSE:01093: 11.43

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

CSPC Pharmaceutical Group's adjusted earnings per share data for the three months ended in Dec. 2023 was HK$0.127. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is HK$0.59 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


CSPC Pharmaceutical Group Shiller PE Ratio Historical Data

The historical data trend for CSPC Pharmaceutical Group's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Shiller PE Ratio Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 12.26

CSPC Pharmaceutical Group Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 12.26

Competitive Comparison of CSPC Pharmaceutical Group's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's Shiller PE Ratio falls into.



CSPC Pharmaceutical Group Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CSPC Pharmaceutical Group's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=6.73/0.59
=11.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSPC Pharmaceutical Group's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, CSPC Pharmaceutical Group's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.127/114.6694*114.6694
=0.127

Current CPI (Dec. 2023) = 114.6694.

CSPC Pharmaceutical Group Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200312 0.000 72.808 0.000
200412 0.000 74.488 0.000
200512 0.000 75.666 0.000
200612 0.000 77.793 0.000
200712 0.000 82.911 0.000
200812 0.000 83.956 0.000
200906 0.181 83.615 0.248
200912 0.148 85.386 0.199
201006 0.144 85.886 0.192
201012 0.106 89.289 0.136
201106 0.090 91.612 0.113
201112 0.028 92.885 0.035
201206 0.029 93.495 0.036
201212 0.241 95.237 0.290
201306 0.046 95.984 0.055
201312 0.039 97.624 0.046
201406 0.052 98.200 0.061
201412 0.058 99.000 0.067
201506 0.072 99.500 0.083
201512 0.077 100.600 0.088
201606 0.091 101.400 0.103
201612 0.097 102.600 0.108
201706 0.113 103.100 0.126
201712 0.118 104.500 0.129
201806 0.152 104.900 0.166
201812 0.149 106.500 0.160
201906 0.178 107.700 0.190
201912 0.171 111.200 0.176
202006 0.212 110.400 0.220
202012 0.282 111.500 0.290
202106 0.310 111.769 0.318
202112 0.260 113.108 0.264
202203 0.145 114.335 0.145
202206 0.154 114.558 0.154
202209 0.141 115.339 0.140
202212 0.152 115.116 0.151
202303 0.137 115.116 0.136
202306 0.142 114.558 0.142
202309 0.138 115.339 0.137
202312 0.127 114.669 0.127

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CSPC Pharmaceutical Group  (HKSE:01093) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


CSPC Pharmaceutical Group Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group (HKSE:01093) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (HKSE:01093) Headlines

No Headlines